Pharmacy benefit management company.
Acquired by TPG Capital2015-06-01
Managing prescription drug benefits to control costs.
Envision Pharmaceutical Services will see a rise in prescription drug costs for consumers as the company takes on more debt and seeks to maximize profits through dividend recapitalization
Consumers may experience longer wait times and more administrative hurdles when trying to access their prescriptions as the company focuses on cost-cutting measures like staff reductions
The quality and reliability of Envision's pharmacy benefits management services may decline as the company defers maintenance and upgrades to its technology and infrastructure
Announcements about 'streamlining operations' and 'improving efficiency'
First round of staff reductions announced, some IT system upgrades delayed
Noticeable increase in prescription processing times and consumer complaints, limited access to certain drugs
Significant increase in prescription costs for consumers, more reports of service disruptions and technical issues
Potential for Envision to file for bankruptcy or be sold off as its ability to effectively manage pharmacy benefits declines
Closely monitor any changes to your prescription drug coverage and costs, and be prepared to advocate for yourself if you experience disruptions or quality declines in Envision's services
Stay informed about Envision's financial situation and any potential changes in ownership or leadership, as this could impact the stability and reliability of your pharmacy benefits
Consider exploring alternative pharmacy benefit providers or programs that may be less affected by PE ownership and cost-cutting measures
Look for family-owned or employee-owned businesses